INTERMEDIATE GRADE B-CELL NON-HODGKIN'S LYMPHOMA

Clinical trials for INTERMEDIATE GRADE B-CELL NON-HODGKIN'S LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new INTERMEDIATE GRADE B-CELL NON-HODGKIN'S LYMPHOMA trials appear

Sign up with your email to follow new studies for INTERMEDIATE GRADE B-CELL NON-HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test 'Double Punch' immune therapy to stop tough lymphoma

Disease control Recruiting now

This early-stage study is testing the safety and feasibility of a two-part treatment for aggressive B-cell lymphoma that has come back or is not responding to other therapies. Doctors take a patient's own immune cells, modify them in a lab to better target cancer, and then infuse…

Matched conditions: INTERMEDIATE GRADE B-CELL NON-HODGKIN'S LYMPHOMA

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

INTERMEDIATE GRADE B-CELL NON-HODGKIN'S LYMPHOMA

Get alerted when new INTERMEDIATE GRADE B-CELL NON-HODGKIN'S LYMPHOMA trials appear

Scientists test 'Double Punch' immune therapy to stop tough lymphoma